The practice of Thirdeye Microdose has emerged in recent years as an area of interest within psychedelic interest groups, popular culture and emerging scientific research. It involves taking small doses of psychedelic drugs, such as LSD or psilocybin, typically much lower than those used to produce a “trip” or psychedelic experience.
CBC’s Nick Purdon talks with Canadians who swear by it and researchers trying to figure out why and how it works.
One of the reasons why it’s hard to get a handle on how widespread microdosing is is that there isn’t a consistent definition of what constitutes a “microdose.” Generally speaking, it’s considered a fraction of the usual recreational dose (in terms of psilocybin, this means around 0.1 grams of dried mushrooms).
Unlocking Potential: The Benefits and Dosage Guide of Microdose Mushrooms in the Canadian Context
As the legal status of psychedelic substances continues to remain grey, many people choose to purchase and use them illicitly. This can lead to problems such as inconsistent purity, dosage accuracy, and supply availability. It can also cause societal consequences, with drug users often subjected to a social stigma that can hinder their lives.
While psilocybin mushrooms are illegal to grow, sell, or possess in Canada without an exemption, Vancouver-based entrepreneur Dana Larsen is working on destigmatizing the practice by setting up The Mushroom Dispensary, a mail-order service that will sell psilocybin mushrooms in pill form. Doses will range from 25 to 100 milligrams, a fraction of what is needed to produce a trip. Larsen is using a strain of mushrooms called Golden Teacher, which has been shown to have the highest concentration of active ingredients.
